Advertisement

Reactions Weekly

, Volume 1776, Issue 1, pp 25–25 | Cite as

Alemtuzumab

CNS T cell lymphoproliferative disease: case report
Case report
  • 20 Downloads

Reference

  1. Horton L, et al. Central nervous system t cell lymphoproliferative disease following treatment with alemtuzumab. Neurology 92 (Suppl.): no pagination abstr. P4.2-020, No. 15, 09 Apr 2019. Available from: URL: https://n.neurology.org/content/92/15_Supplement/P4.2-020 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations